{"key":"op_284_AT","page":{"url":"https://it.bookimed.com/clinics/country=austria/procedure=targeted-therapy/","procedure":{"id":284,"slug":"targeted-therapy","name":"Terapia mirata","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":29,"iso":"AT","name":"Austria"},"currency":"USD","data_date":"2026-10-02"},"pages":{"clinics_url":"https://it.bookimed.com/clinics/country=austria/procedure=targeted-therapy/","cost_url":"https://it.bookimed.com/clinics/country=austria/procedure=targeted-therapy/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":9000,"to":21000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":9000,"to":20000},"uk":{"from":3800,"to":9500},"by_technique":[{"technique":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","technique_id":"small-molecule-inhibitors","price_from":9000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Monoclonal antibodies (intravenous or subcutaneous)","technique_id":"monoclonal-antibodies","price_from":11000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Antibody-drug conjugates","technique_id":"antibody-drug-conjugates","price_from":15000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Vienna","from":4500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":1800,"to":4800},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":3800,"to":9500},{"country_iso":"US","from":9000,"to":20000},{"country_iso":"IL","from":6500,"to":12500},{"country_iso":"TR","from":3000,"to":6000},{"country_iso":"MX","from":3500,"to":8000},{"country_iso":"DE","from":3000,"to":13500},{"country_iso":"CA","from":9000,"to":24000},{"country_iso":"AE","from":6500,"to":14000},{"country_iso":"TH","from":1000,"to":9000},{"country_iso":"PL","from":2500,"to":6000},{"country_iso":"KR","from":6500,"to":12500},{"country_iso":"CZ","from":3500,"to":8000},{"country_iso":"ES","from":13500,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"IT","from":4500,"to":9000},{"country_iso":"CN","from":3500,"to":11000},{"country_iso":"AU","from":9000,"to":21000},{"country_iso":"IN","from":1000,"to":8500},{"country_iso":"MY","from":6500,"to":13500},{"country_iso":"VN","from":4500,"to":9500},{"country_iso":"BR","from":4500,"to":7000},{"country_iso":"EG","from":1000,"to":4800}],"base_country":"US","base_is_fallback":false},"savings":{"pct":0,"variant":"ranges_overlap"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":1,"items":[{"id":46,"name":"Wiener Privatklinik (WPK)","city":"Vienna","rating":4.6,"reviews_count":175,"accreditations":["World's Best Hospitals 2021 by Newsweek","International Organization for Standardization","World's Best Hospitals 2022 by Newsweek","ISO 9001:2015 Quality management systems","World's Best Hospitals 2026 by Newsweek","World's Best Hospitals 2025 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Every case reviewed by an interdisciplinary tumour board. Liquid biopsy blood test detects early tumours. Oncologist among top 2% of scientists worldwide. ISO 9001 certified.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":2,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":84,"slug":"vienna","name":"Vienna","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4500,"profile":{"city_type":"Capital and largest city of Austria","access":["Vienna Airport (VIE), 18 km from central Vienna"],"sources":["https://en.wikipedia.org/wiki/Vienna","https://en.wikipedia.org/wiki/Vienna_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Cancers with molecular targets: HER2, EGFR, ALK, BRAF, BCR-ABL","Hematologic malignancies and solid tumors with a matched targeted agent","Some non-cancer conditions with defined molecular targets"],"contraindications":["Known severe hypersensitivity to the specific agent or its components","Pregnancy and breastfeeding for many agents (agent-specific)","Severe uncontrolled liver, heart or lung dysfunction (relative, agent-dependent)","Clinically significant drug interactions with the specific agent (relative, agent-specific)"],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Per infusion visit; first infusion is longest. Oral agents are taken at home."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":13,"unit":"visits","qualifier":"Infusion-based schedule every 1-3 weeks until first imaging; oral agents need no infusion visits."},"stages":[{"code":"biomarker_confirmation","label":"Biomarker confirmation and baseline tests","after":{"min":0,"max":0,"unit":"days","qualifier":"Before first dose."}},{"code":"treatment_start","label":"First dose or infusion","after":{"min":0,"max":7,"unit":"days","qualifier":"Starts once testing is confirmed."}},{"code":"response_assessment","label":"First response imaging","after":{"min":56,"max":90,"unit":"days","qualifier":"After several cycles."}}],"qualifier":"Treatment continues until progression or intolerance; typical first-phase schedule shown."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Typical oral or infusion-based cycles are given without overnight stay; inpatient stay is not usual for uncomplicated treatment."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":3,"unit":"days","qualifier":"Ordinary activity resumes quickly; longer if infusion reactions or fatigue occur."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first dose, oncology team usually wants early tolerance observed; depends on agent and infusion reactions."},"back_to_work_days":{"min":0,"max":3,"unit":"days","qualifier":"Most patients keep working; depends on agent side effects and infusion schedule."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually continues; intensity limited by fatigue, rash, diarrhea or cardiac precautions."},"final_result_months":{"min":2,"max":6,"unit":"months","qualifier":"Response is judged by imaging after several cycles; depends on tumor type and agent."},"result_longevity":"Response lasts as long as the drug is effective, often months to several years. Acquired resistance eventually develops in many cancers.","main_risks":["Skin reactions such as rash and dryness","Diarrhea, nausea and other gastrointestinal effects","Liver enzyme elevation","Hypertension, cardiac effects or bleeding with certain agents","Infusion reactions with antibody-based agents","Blood count changes"],"complication_rate_pct":{"min":20,"max":50,"unit":"percent","qualifier":"Grade 3-4 adverse events during treatment; any-grade side effects are far more common, varying by agent."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective tumor response rate at first imaging","value":60,"horizon":"2-3 months","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No incisions or scars; only minor puncture marks from IV cannulation.","pain":"Treatment itself is painless apart from IV cannulation. Side effects such as rash, mouth sores or joint aches are usually mild to moderate.","preparation":["Molecular target or biomarker confirmed by tissue or blood testing","Baseline blood tests and organ function assessment","Review of current medications and supplements with the oncology team","Baseline cardiac or other agent-specific assessment where required","Discussion of expected side effects and contraception where relevant"],"recovery_timeline":[{"phase":"Treatment day","description":"Oral dose started or infusion given with observation for reactions.","restrictions":["Report fever or breathing difficulty immediately","Follow agent-specific food and drug rules"]},{"phase":"First 2 weeks","description":"Early side effects such as rash, diarrhea or fatigue may appear and are managed with supportive care.","restrictions":["Avoid sun exposure","Avoid new supplements without approval"]},{"phase":"Ongoing cycles","description":"Treatment continues with periodic blood tests and imaging to assess response.","restrictions":["Contraception where relevant","Avoid grapefruit with some agents"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":21,"unit":"days","qualifier":"Early tolerance check with blood tests and side-effect review."}},{"purpose":"result_review","requirement":"routine","after":{"min":56,"max":90,"unit":"days","qualifier":"First response imaging and blood markers; timing depends on agent and cancer type."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your tumor has been tested for the drug's target. Why: the drug is chosen for a specific target found in the tumor","scope":"procedure","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check the qualifications of the medical team that will treat you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Make sure you are clear how your aftercare will be coordinated after treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers to book now","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"The doctor you consult may not be the one who actually treats you","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F3","text":"Adverts or information promising complete success for the treatment","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Unusual bleeding or bruising during targeted therapy","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/bleeding-bruising","host":"cancer.gov","quote":"Some cancer treatments, such as chemotherapy and targeted therapy, can increase your risk of bleeding and bruising.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Diarrhea that lasts or becomes more severe","urgency":"contact_clinic","general":false,"source":{"url":"https://cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Ask the health care team about when you should call them if the diarrhea lasts or becomes more severe.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever higher than your care team expects","urgency":"contact_clinic","general":true,"source":{"url":"https://mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/targeted-therapy-side-effects.html","host":"mdanderson.org","quote":"A fever higher than what your care team told you to expect","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows which follow-up tests are due and which doctors are responsible for care","document":"written aftercare plan","source":{"url":"https://www.cdc.gov/cancer/survivors/life-after-cancer/survivorship-care-plans.htm","host":"cdc.gov","quote":"Your plan should say when you need to get follow-up tests, and which doctors are responsible for your care.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}},{"id":"T2","text":"Gives the home doctor an up-to-date, clear picture of the treatment received","document":"end of treatment summary","source":{"url":"https://cht.nhs.uk/services/clinical-services/oncology/end-of-treatment-summary","host":"cht.nhs.uk","quote":"It also provides the GP with an up-to-date and clear understanding of the patient's treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Blood test","Blood test results","Blood testing"],"kind":"lab","origin":[{"field":"preparation","text":"Molecular target or biomarker confirmed by tissue or blood testing"},{"field":"preparation","text":"Baseline blood tests and organ function assessment"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Genomic testing","aliases":["Genomic testing","Molecular or genomic testing","Molecular testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Molecular or genomic testing report"}],"what_it_checks":{"text":"Helps doctors tailor the targeted treatment to the individual patient","source":{"url":"https://www.ncbi.nlm.nih.gov/sites/books/n/nap21860/ch1/","host":"ncbi.nlm.nih.gov","quote":"Such predictive biomarker tests are used by health care providers to tailor treatment to an individual patient's clinical condition and treatment goals.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"CT scan","aliases":["CT scan","CT","CT scans","Computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET-CT scans","PET CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood biochemistry test","aliases":["Blood biochemistry test","Biochemistry blood test"],"kind":"lab","origin":[{"field":"packages","text":"Biochemistry blood test"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":3,"unit":"days","qualifier":"Most patients keep working; depends on agent side effects and infusion schedule."},"complication_rate_pct":{"min":20,"max":50,"unit":"percent","qualifier":"Grade 3-4 adverse events during treatment; any-grade side effects are far more common, varying by agent."},"contraindications":["Known severe hypersensitivity to the specific agent or its components","Pregnancy and breastfeeding for many agents (agent-specific)","Severe uncontrolled liver, heart or lung dysfunction (relative, agent-dependent)","Clinically significant drug interactions with the specific agent (relative, agent-specific)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Typical oral or infusion-based cycles are given without overnight stay; inpatient stay is not usual for uncomplicated treatment."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually continues; intensity limited by fatigue, rash, diarrhea or cardiac precautions."},"final_result_months":{"min":2,"max":6,"unit":"months","qualifier":"Response is judged by imaging after several cycles; depends on tumor type and agent."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first dose, oncology team usually wants early tolerance observed; depends on agent and infusion reactions."},"follow_up_visits":[{"purpose":"assessment","after":{"min":7,"max":21,"unit":"days","qualifier":"Early tolerance check with blood tests and side-effect review."},"requirement":"routine"},{"purpose":"result_review","after":{"min":56,"max":90,"unit":"days","qualifier":"First response imaging and blood markers; timing depends on agent and cancer type."},"requirement":"routine"}],"indications":["Cancers with molecular targets: HER2, EGFR, ALK, BRAF, BCR-ABL","Hematologic malignancies and solid tumors with a matched targeted agent","Some non-cancer conditions with defined molecular targets"],"main_risks":["Skin reactions such as rash and dryness","Diarrhea, nausea and other gastrointestinal effects","Liver enzyme elevation","Hypertension, cardiac effects or bleeding with certain agents","Infusion reactions with antibody-based agents","Blood count changes"],"pain":"Treatment itself is painless apart from IV cannulation. Side effects such as rash, mouth sores or joint aches are usually mild to moderate.","preparation":["Molecular target or biomarker confirmed by tissue or blood testing","Baseline blood tests and organ function assessment","Review of current medications and supplements with the oncology team","Baseline cardiac or other agent-specific assessment where required","Discussion of expected side effects and contraception where relevant"],"recovery_timeline":[{"phase":"Treatment day","description":"Oral dose started or infusion given with observation for reactions.","restrictions":["Report fever or breathing difficulty immediately","Follow agent-specific food and drug rules"]},{"phase":"First 2 weeks","description":"Early side effects such as rash, diarrhea or fatigue may appear and are managed with supportive care.","restrictions":["Avoid sun exposure","Avoid new supplements without approval"]},{"phase":"Ongoing cycles","description":"Treatment continues with periodic blood tests and imaging to assess response.","restrictions":["Contraception where relevant","Avoid grapefruit with some agents"]}],"rehabilitation_days":{"min":0,"max":3,"unit":"days","qualifier":"Ordinary activity resumes quickly; longer if infusion reactions or fatigue occur."},"result_longevity":"Response lasts as long as the drug is effective, often months to several years. Acquired resistance eventually develops in many cancers.","revision_rate_pct":null,"scars":"No incisions or scars; only minor puncture marks from IV cannulation.","sessions_or_stages":{"sessions":{"min":4,"max":13,"unit":"visits","qualifier":"Infusion-based schedule every 1-3 weeks until first imaging; oral agents need no infusion visits."},"stages":[{"code":"biomarker_confirmation","label":"Biomarker confirmation and baseline tests","after":{"min":0,"max":0,"unit":"days","qualifier":"Before first dose."}},{"code":"treatment_start","label":"First dose or infusion","after":{"min":0,"max":7,"unit":"days","qualifier":"Starts once testing is confirmed."}},{"code":"response_assessment","label":"First response imaging","after":{"min":56,"max":90,"unit":"days","qualifier":"After several cycles."}}],"qualifier":"Treatment continues until progression or intolerance; typical first-phase schedule shown."},"success":{"metric":"Objective tumor response rate at first imaging","value":60,"unit":"percent","horizon":"2-3 months","population":"Adults with biomarker-matched advanced cancer receiving a matched targeted agent","evidence_status":"limited"},"techniques":[{"name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","suits_whom":"Patients whose tumor carries a matching targetable alteration","recovery":"No recovery period; usually taken continuously at home with periodic monitoring."},{"name":"Monoclonal antibodies (intravenous or subcutaneous)","suits_whom":"Patients with target-expressing tumors such as HER2-positive cancers","recovery":"Given at scheduled infusion visits; usually no recovery time beyond infusion-related effects."},{"name":"Antibody-drug conjugates","suits_whom":"Selected patients with target-expressing cancers and suitable prior treatment history","recovery":"Given at scheduled infusion visits with monitoring for agent-specific toxicity."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Per infusion visit; first infusion is longest. Oral agents are taken at home."},"initial_assessment_documents":["Pathology report with tumor type and stage","Molecular or genomic testing report","Recent CT or PET-CT scans","Summary of previous cancer treatments","Recent blood test results","Oncologist's latest treatment notes (if available)"],"travel_trips":{"min":2,"max":3,"one_trip_possible":false,"qualifier":"Start visit with first dose and tolerance check, then response imaging at 2-3 months; routine monitoring at home."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your tumor has been tested for the drug's target. Why: the drug is chosen for a specific target found in the tumor","scope":"procedure","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check the qualifications of the medical team that will treat you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Make sure you are clear how your aftercare will be coordinated after treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers to book now","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"The doctor you consult may not be the one who actually treats you","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F3","text":"Adverts or information promising complete success for the treatment","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Unusual bleeding or bruising during targeted therapy","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/bleeding-bruising","host":"cancer.gov","quote":"Some cancer treatments, such as chemotherapy and targeted therapy, can increase your risk of bleeding and bruising.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Diarrhea that lasts or becomes more severe","urgency":"contact_clinic","general":false,"source":{"url":"https://cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Ask the health care team about when you should call them if the diarrhea lasts or becomes more severe.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever higher than your care team expects","urgency":"contact_clinic","general":true,"source":{"url":"https://mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/targeted-therapy-side-effects.html","host":"mdanderson.org","quote":"A fever higher than what your care team told you to expect","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows which follow-up tests are due and which doctors are responsible for care","document":"written aftercare plan","source":{"url":"https://www.cdc.gov/cancer/survivors/life-after-cancer/survivorship-care-plans.htm","host":"cdc.gov","quote":"Your plan should say when you need to get follow-up tests, and which doctors are responsible for your care.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}},{"id":"T2","text":"Gives the home doctor an up-to-date, clear picture of the treatment received","document":"end of treatment summary","source":{"url":"https://cht.nhs.uk/services/clinical-services/oncology/end-of-treatment-summary","host":"cht.nhs.uk","quote":"It also provides the GP with an up-to-date and clear understanding of the patient's treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You want a treatment that may slow or stop cancer growth","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy can be used to cure cancer, lessen the chance it will return, or stop or slow its growth.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37},{"id":"A2","text":"You want treatment that helps your immune system fight the cancer","name":"Immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":283}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"small-molecule-inhibitors","name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","how_it_works":{"text":"Small drugs enter cells and act on targets inside them","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"monoclonal-antibodies","name":"Monoclonal antibodies (intravenous or subcutaneous)","how_it_works":{"text":"Antibodies attach to specific targets found on cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"These proteins are designed to attach to specific targets found on cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-drug-conjugates","name":"Antibody-drug conjugates","how_it_works":{"text":"Antibodies are linked to cell-killing substances that reach cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Some monoclonal antibodies are combined with cell-killing substances such as toxins, chemotherapy drugs, or radiation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Blood test","Blood test results","Blood testing"],"kind":"lab","origin":[{"field":"preparation","text":"Molecular target or biomarker confirmed by tissue or blood testing"},{"field":"preparation","text":"Baseline blood tests and organ function assessment"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Genomic testing","aliases":["Genomic testing","Molecular or genomic testing","Molecular testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Molecular or genomic testing report"}],"what_it_checks":{"text":"Helps doctors tailor the targeted treatment to the individual patient","source":{"url":"https://www.ncbi.nlm.nih.gov/sites/books/n/nap21860/ch1/","host":"ncbi.nlm.nih.gov","quote":"Such predictive biomarker tests are used by health care providers to tailor treatment to an individual patient's clinical condition and treatment goals.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"CT scan","aliases":["CT scan","CT","CT scans","Computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET-CT scans","PET CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET-CT scans"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood biochemistry test","aliases":["Blood biochemistry test","Biochemistry blood test"],"kind":"lab","origin":[{"field":"packages","text":"Biochemistry blood test"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"small-molecule-inhibitors","name":"Small-molecule inhibitors (oral, e.g. tyrosine kinase inhibitors)","how_it_works":{"id":"H1","text":"Small drugs enter cells and act on targets inside them","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients whose tumor carries a matching targetable alteration","price_from":9000,"recovery":"No recovery period; usually taken continuously at home with periodic monitoring."},{"id":"monoclonal-antibodies","name":"Monoclonal antibodies (intravenous or subcutaneous)","how_it_works":{"id":"H1","text":"Antibodies attach to specific targets found on cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"These proteins are designed to attach to specific targets found on cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with target-expressing tumors such as HER2-positive cancers","price_from":11000,"recovery":"Given at scheduled infusion visits; usually no recovery time beyond infusion-related effects."},{"id":"antibody-drug-conjugates","name":"Antibody-drug conjugates","how_it_works":{"id":"H1","text":"Antibodies are linked to cell-killing substances that reach cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet","host":"cancer.gov","quote":"Some monoclonal antibodies are combined with cell-killing substances such as toxins, chemotherapy drugs, or radiation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with target-expressing cancers and suitable prior treatment history","price_from":15000,"recovery":"Given at scheduled infusion visits with monitoring for agent-specific toxicity."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You want a treatment that may slow or stop cancer growth","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy can be used to cure cancer, lessen the chance it will return, or stop or slow its growth.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37},{"id":"A2","text":"You want treatment that helps your immune system fight the cancer","name":"Immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":283}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK passport holders can visit Austria without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/austria/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area, which includes Austria, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"Prospective residents, and anyone planning to stay longer than 90 days, must obtain the appropriate visa","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Austria.html","host":"travel.state.gov","quote":"Prospective residents or anyone intending to  stay longer than 90 days  must obtain the appropriate visa.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must have an expiry date at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/austria/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport should be valid for at least three months beyond the period of stay in Austria","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Austria.html","host":"travel.state.gov","quote":"Your passport should be valid for at least three months beyond the period of stay  if you plan on transiting a Schengen country review our  U.S. Travelers in Europe page.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"all","volatile":false,"text":"Austria does not allow importing any pharmaceuticals that contain narcotic drugs or psychotropic substances","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Austria.html","host":"travel.state.gov","quote":"Austria does not allow the importation of any pharmaceuticals that contain narcotic drugs or psychotropic substances.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"ghic","audience":"uk","volatile":false,"text":"To get medically necessary state healthcare in Austria, UK travelers need a GHIC or an EHIC","source":{"url":"https://www.gov.uk/foreign-travel-advice/austria/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Austria, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V7","item":"hospital_payment","audience":"all","volatile":false,"text":"Hospitals and doctors in Austria often require payment up front or adequate health insurance before service or admission","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Austria.html","host":"travel.state.gov","quote":"Hospitals and doctors often require payment “up front” or adequate health insurance prior to service or admission.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V8","item":"emergency_number","audience":"all","volatile":false,"text":"To call an ambulance in Austria, dial 144","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Austria.html","host":"travel.state.gov","quote":"To call an ambulance, dial 144.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","china","egypt","germany","india","israel","italy","latvia","malaysia","poland","republic-of-korea","spain","switzerland","thailand","turkey","ukraine","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.6,"count":175,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Targeted therapy in Austria typically costs from _op_284_price_from_ to _op_284_price_to_. The final price depends on the molecular profile of the tumor and drug costs. In the US, similar procedures cost around _price_compare_US_average_ on average. Patients save around _price_percent_discount_% compared to the US. Costs in Austria usually include initial consultations and tumor board reviews.</p>\n\n<ul>\n<li><strong>Lutetium-177 therapy:</strong> _op_830_price_from_ to _op_830_price_to_ for advanced prostate cancer or neuroendocrine tumors.</li>\n<li><strong>Actinium-225 therapy:</strong> _op_1653_price_from_ to _op_1653_price_to_ for alpha-emitting radiation treatment.</li>\n<li><strong>Biological therapy:</strong> Often ranges between 15-20% higher than baseline targeted protocols.</li>\n<li><strong>Vienna medical hubs:</strong> Private facilities in Vienna typically command a 15-20% premium.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> While Vienna carries a premium, the value lies in accessing world-class university expertise. At Wiener Privatklinik, over 400 physicians collaborate, many serving as professors at Medical University of Vienna. Expert oncologists like Dr. Wolfgang Köstler bring experience from Memorial Sloan-Kettering Cancer Center. This academic connection ensures patients receive the latest personalized medicine protocols. Initial oncology consultations in Vienna typically run approximately $400 to $500.</p>","faq":[{"q":"What is targeted therapy and how is it approached in Austria?","a":"<p>Targeted therapy in Austria is a precision medicine approach using molecular oncology to block specific proteins or genes fueling cancer growth. Austrian clinics like Wiener Privatklinik utilize next-generation sequencing and biomarker testing to create individualized systemic treatments that spare healthy tissue and minimize systemic side effects.</p> <ul> <li><strong>Molecular profiling:</strong> Specialists use genomic testing to identify specific mutations like EGFR or HER2.</li> <li><strong>Interdisciplinary boards:</strong> Experts from university medical hubs collectively design protocols for complex cases.</li> <li><strong>Advanced medications:</strong> Therapy utilizes specific drugs to inhibit cancer signals and overcome drug resistance.</li> <li><strong>Specialized centers:</strong> Treatment occurs in ISO-certified facilities like Wiener Privatklinik under molecular biology experts.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While basic oncology is widespread, Austria stands out for its high density of molecular biology experts. At Wiener Privatklinik, surgeons like Professor Wolfgang Köstler combine clinical work with research from the Weizmann Institute. This allows patients to access specific targeted drugs that effectively overcome tumor resistance patterns.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that accessing these therapies requires providing detailed documentation of all previous treatments. Consensus suggests focusing on major oncology centers since targeted options are rarely available as walk-in services.</p>"},{"q":"Which top medical centers and clinics in Austria specialize in precision oncology and targeted treatments?","a":"<p>Top medical centers in Austria for precision oncology include Wiener Privatklinik (WPK), Vienna General Hospital (AKH), and University Hospital Innsbruck. These facilities utilize molecular profiling and targeted systemic therapies to treat cancer based on genetic biomarkers. Patients access advanced drug protocols and high-tech radiation like carbon-ion therapy.</p> <ul> <li><strong>Specialized diagnostics:</strong> Advanced molecular and genetic tumor profiling guides individualized treatment plans.</li> <li><strong>Academic expertise:</strong> Prof. Wolfgang Köstler at WPK integrates molecular oncology with targeted systemic therapy.</li> <li><strong>Radiation technology:</strong> MedAustron provides specialized proton and carbon-ion therapy for radiation-resistant tumors.</li> <li><strong>Quality standards:</strong> Wiener Privatklinik (WPK) holds ISO 9001 and Newsweek Best Hospital certifications.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Vienna is the primary academic hub, private clinics like WPK offer unique accessibility. With 300 doctors and 12,000 annual patients, WPK provides rapid molecular results. This speed is critical for initiating targeted therapies compared to larger public systems. </p> <p><strong>Patient Consensus:</strong> Patients emphasize that Austria is a top destination for subspecialized cancer care. They recommend prioritizing large tertiary centers for complex cases to ensure access to molecular tumor boards.</p>"},{"q":"What types of cancers are commonly treated with targeted therapy protocols in Austria?","a":"<p>Austrian oncology centers provide targeted therapy for breast, lung, colorectal, and prostate cancers. Treatment protocols utilize molecular profiling and biomarker testing to identify specific genetic mutations. Specialized clinics like Wiener Privatklinik integrate personalized medicine, leveraging monoclonal antibodies, tyrosine kinase inhibitors, and advanced radioligand therapies.</p> <ul> <li><strong>Lung cancer:</strong> Protocols target EGFR mutations, ALK rearrangements, and ROS1 in non-small cell lung cancer.</li> <li><strong>Breast cancer:</strong> Clinicians use monoclonal antibodies and CDK4/6 inhibitors for HER2-positive and hormone-receptor-positive subtypes.</li> <li><strong>Prostate cancer:</strong> Advanced cases utilize Lutetium-177 radioligand therapy to target specific metastatic cell receptors.</li> <li><strong>Skin cancers:</strong> Specialists combine BRAF and MEK inhibitors to treat advanced mutation-positive cutaneous melanoma.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many countries offer standard targeted drugs, Austria stands out for its molecular oncology leadership. Clinics like Wiener Privatklinik host top experts like Dr. Wolfgang Köstler. His background at Memorial Sloan–Kettering highlights the focus on overcoming drug resistance. This expertise is vital when first-line therapies fail.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that targeted therapy is mutation-driven rather than a general solution. Many suggest seeking care at specialized oncology centers to ensure access to comprehensive molecular profiling.</p>"},{"q":"How can international patients arrange a consultation or a second opinion for targeted therapy in Austria?","a":"<p>International patients arrange consultations for targeted therapy in Austria by contacting specialized international offices at private Vienna hospitals. The process involves submitting molecular profiling results and pathology reports for multidisciplinary tumor board review. Leading oncologists provide remote second opinions and individualized systemic therapy plans via telehealth portals.</p> <ul> <li><strong>Medical documentation:</strong> Provide histopathology, genetic profiling, and DICOM imaging files.</li> <li><strong>Specialized facilities:</strong> Wiener Privatklinik offers dedicated international departments for complex oncology.</li> <li><strong>Remote assessments:</strong> Telehealth consultations allow for written evaluations without initial travel.</li> <li><strong>Expert coordination:</strong> University-affiliated professors manage biomarker-based precision oncology strategies.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Vienna clinics like Wiener Privatklinik handle over 7,000 international patients annually, reflecting a high-volume infrastructure for cross-border care. Dr. Wolfgang Köstler combines molecular biology expertise with clinical oncology, which is vital for patients seeking specific resistance mechanism analysis. Choosing a clinic with ISO 9001 certification ensures standardized documentation for seamless second opinions.</p> <p><strong>Patient Consensus:</strong> Patients recommend sending a concise summary from a home oncologist to accelerate the triage process. Clarity on whether the visit is for a second opinion or immediate treatment helps manage financial expectations early.</p>"}],"h2":[{"text":"Qual è il prezzo di Terapia mirata in Austria? Scoprilo ora","kind":"content"},{"text":"I tuoi benefici e le tue garanzie con Bookimed","kind":"content"},{"text":"Il tuo coordinatore medico Bookimed personale","kind":"content"},{"text":"Scopri le migliori cliniche di Terapia mirata in Austria: 1 opzioni verificate e Prezzi","kind":"content"},{"text":"Panoramica di Terapia mirata in Austria","kind":"content"},{"text":"Ottieni una valutazione medica per Terapia mirata in Austria: scegli il tuo specialista tra i migliori nel settore","kind":"content"},{"text":"Storie in video dei pazienti Bookimed","kind":"content"},{"text":"Recensioni","kind":"content"},{"text":"Condividi contenuto","kind":"content"},{"text":"Domande frequenti su Terapia mirata in Austria","kind":"content"},{"text":"Richiedi una consulenza gratuita","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}